SNAI2 and lung cancer: The disagreement to the previous observation that the high expression of miR-181a-5p increases the cisplatin sensitivity of A549 lung cancer cells by suppressing MAPK/Slug pathway and regulates EMT by targeting PTEN [36, 37] perhaps could be attributed to the specificity of the model system used.